Mayne receives Australian court decision for Epirubicin

09-Aug-2005

Mayne Group Limited advises that the Federal Court of Australia (Victorian Division) has ruled that Mayne Pharma's formulation of Epirubicin infringes a patent of the innovator - Pharmacia Italia S.P.A. (a subsidiary of Pfizer, Inc.). Mayne will consider appealing this ruling. In addition, Mayne is challenging the validity of the extension of the Australian patent which runs from June 2006 to June 2011.

Other news from the department politics & laws

Most read news

More news from our other portals

Discover the latest developments in battery technology!